Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920058 · ClinicalTrials.gov registry record · NA
Optimal Metabolic Health Through Continuous Glucose Monitoring
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT04920058 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 66 participants.
The verdict
NCT04920058, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The primary focus of this study is to evaluate the role of Continuous Glucose Monitoring (CGM) with Levels Health software as a tool to provide feedback and accountability necessary to create sustainable behavioral changes in nutrition associated with improved metabolic health and resilience against chronic and infectious diseases.
Interventions
- DEVICE Continuous Glucose Monitor
- OTHER <Active Comparator?>
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-05-10 |
| Est. Completion | 2022-04-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04920058
The ClinicalTrials.gov registry entry for NCT04920058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitor is the first listed.
NCT04920058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04920058 about?
NCT04920058 is a clinical study titled "Optimal Metabolic Health Through Continuous Glucose Monitoring". The primary focus of this study is to evaluate the role of Continuous Glucose Monitoring (CGM) with Levels Health software as a tool to provide feedback and accountability necessary to create sustainable behavioral changes in nutrition associated with improved metabolic health and resilience against...
What is the current status of trial NCT04920058?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2021-05-10. Estimated completion is 2022-04-18.
What interventions are being tested in trial NCT04920058?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE), <Active Comparator?> (OTHER).
Who is sponsoring clinical trial NCT04920058?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.